5-(3-吲哚基甲基)-3-N-甲基海因 | 74311-00-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 中文名称: 5-(3-吲哚基甲基)-3-N-甲基海因
• 中文别名: 2,5-二氢-1,3-噻唑-4-羧酸
• 英文名称: necrostatin-1
• 英文别名: nec-1；3-Methyl-5-(1H-indol-3-ylmethyl)-imidazolidine-2,4-dione；5-(1H-indol-3-ylmethyl)-3-methylimidazolidine-2,4-dione
• CAS: 74311-00-5
• 化学式: C₁₃H₁₃N₃O₂
• 分子量: 243.265
• InChiKey: PANAMPMZPUJRLL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  65.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  5-(1H-Indol-3-ylmethylene)-3-methylimidazolidine-2,4-dione 在 sodium tetrahydroborate 、 CoCl₂ 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 以66%的产率得到5-(3-吲哚基甲基)-3-N-甲基海因
  参考文献：
  名称：

  Inhibitors of cellular necrosis

  摘要：

  本发明涉及化合物、药物制剂及其在预防或治疗与细胞死亡相关的创伤、缺血、中风和退行性疾病中的应用的治疗。本发明的方法和组合物特别适用于治疗与细胞坏死相关的神经系统疾病。

  公开号：

  US20050119260A1

文献信息

• [EN] METHYL JASMONATE DERIVATIVES AS POSSIBLE DRUG CANDIDATES FOR USE IN TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE JASMONATE DE MÉTHYLE EN TANT QUE CANDIDATS MÉDICAMENTS POSSIBLES POUR UNE UTILISATION DANS LE TRAITEMENT DU CANCER
  申请人：T C ISTANBUL MEDIPOL UNIV

  公开号：WO2019182527A1

  公开（公告）日：2019-09-26

  The present invention relates to the active methyl jasmonate analogues which are effective on the cancer disease and / or on the mechanisms that constitute the disease, the methods of synthesis of said analogs / derivatives and their use in the treatment of a variety of diseases, particularly for treatment of cancer and cancer-causing diseases.

  本发明涉及对癌症疾病有效的活性甲基茉莉酸类似物，以及构成该疾病的机制，所述类似物/衍生物的合成方法以及它们在治疗各种疾病中的应用，特别是用于癌症和致癌疾病的治疗。
• INHIBITORS OF CELLULAR NECROSIS
  申请人：Cuny Gregory D.

  公开号：US20120149702A1

  公开（公告）日：2012-06-14

  The present invention relates to compounds and pharmaceutical preparations and their use in therapy for preventing or treating trauma, ischemia, stroke and degenerative diseases associated with cell death. Methods and compositions of the invention are particularly useful for treating neurological disorders associated with cellular necrosis.

  本发明涉及化合物和药物制剂及其在预防或治疗与细胞死亡相关的创伤、缺血、中风和退行性疾病中的应用。本发明的方法和组合物特别适用于治疗与细胞坏死相关的神经系统疾病。
• Methods for treating spinal cord injury
  申请人：Massachusetts Eye and Ear Infirmary

  公开号：US10022419B2

  公开（公告）日：2018-07-17

  Provided are methods for promoting axon regeneration of a Central Nervous System (CNS) neuron and promoting nerve function following injury to a CNS neuron, for example, brain and/or spinal cord injury. Axon regeneration in a CNS neuron or nerve function following injury to a CNS neuron can be promoted by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject suffering from a CNS disorder, wherein a symptom of the CNS disorder is axon degeneration.

  本文提供了促进中枢神经系统（CNS）神经元轴突再生和促进中枢神经系统神经元损伤后神经功能的方法，例如脑和/或脊髓损伤。中枢神经系统神经元的轴突再生或中枢神经系统神经元损伤后的神经功能可通过向患有中枢神经系统疾病的受试者单独施用坏死抑制剂或与凋亡抑制剂联合施用来促进，其中中枢神经系统疾病的症状是轴突变性。
• Methods and compositions for preserving retinal ganglion cells
  申请人：Massachusetts Eye and Ear Infirmary

  公开号：US10617735B2

  公开（公告）日：2020-04-14

  Provided are methods and compositions for maintaining the viability of retinal ganglion cells in a subject with an ocular disorder including, for example, glaucoma and optic nerve injury. The viability of the retinal ganglion cells can be preserved by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject having an eye with the ocular condition. The compositions, when administered, maintain the viability of the cells and/or promote axon regeneration, thereby minimizing the loss of vision or visual function associated with the ocular disorder.

  本发明提供了维持患有眼部疾病（例如青光眼和视神经损伤）的患者视网膜神经节细胞活力的方法和组合物。通过向患有眼部疾病的患者单独施用坏死抑制剂或与凋亡抑制剂联合施用，可保持视网膜神经节细胞的活力。给药后，组合物可维持细胞的活力和/或促进轴突再生，从而最大程度地减少与眼部疾病相关的视力或视觉功能的丧失。
• Compositions for preserving photoreceptor cells, retinal pigment epithelial cells, or visual function
  申请人：Massachusetts Eye and Ear Infirmary

  公开号：US10639345B2

  公开（公告）日：2020-05-05

  Provided are methods and compositions for maintaining the viability of photoreceptor cells and/or retinal pigment epithelial cells in a subject with an ocular disorder including, for example, age-related macular degeneration (AMD) (e.g., dry or neovascular AMD), retinitis pigmentosa (RP), or a retinal detachment. The viability of the photoreceptor cells and/or the retinal pigment epithelial cells can be preserved by administering a necrosis inhibitor either alone or in combination with an apoptosis inhibitor to a subject having an eye with the ocular condition. The compositions, when administered, maintain the viability of the cells, thereby minimizing the loss of vision or visual function associated with the ocular disorder.

  本发明提供的方法和组合物用于维持患有眼部疾病（例如老年性黄斑变性（AMD）（如干性或新生血管性AMD）、视网膜色素变性（RP）或视网膜脱离）的受试者的感光细胞和/或视网膜色素上皮细胞的活力。对患有眼部疾病的患者单独施用坏死抑制剂或与凋亡抑制剂联合施用，可保持感光细胞和/或视网膜色素上皮细胞的活力。这些组合物在给药后可保持细胞的活力，从而最大程度地减少与眼部疾病相关的视力或视觉功能的丧失。